Literature DB >> 14606649

Redox modulation of NF-kappaB nuclear translocation and DNA binding in metastatic melanoma. The role of endogenous and gamma-glutamyl transferase-dependent oxidative stress.

Silvia Dominici1, Athanase Visvikis, Lisa Pieri, Aldo Paolicchi, Marta A Valentini, Mario Comporti, Alfonso Pompella.   

Abstract

AIMS AND
BACKGROUND: The transcription factor NF-kappaB is implicated in the expression of genes involved in cell proliferation, apoptosis and metastasis. In melanoma, high constitutive levels of NF-kappaB activation are usually observed. NF-kappaB is regulated by oxidation/reduction (redox) processes, and the occurrence of constitutive oxidative stress in melanoma cells has been documented. Recent studies of our laboratories showed that the membrane-bound gamma-glutamyl transferase (GGT) enzyme activity--expressed by a number of malignancies, including melanoma--can act as a basal source of superoxide, hydrogen peroxide and other prooxidants.
METHODS: In the present study we utilized the 2/60 clone of Me665/2 human metastatic melanoma, which displays high levels of GGT activity, in order to verify if the presence of this enzyme--through the promotion of redox processes--may influence the activation status of NF-kappaB. The latter was evaluated by determining the nuclear translocation of the p65 subunit (by immunoblot), the DNA binding of NF-kappaB (by electrophoretic mobility shift assay) and its transcriptional activity (by gene transactivation studies).
RESULTS: Me665/2/60 cells displayed a basal production of hydrogen peroxide. Stimulation of GGT activity by its substrates glutathione and glycyl-glycine caused additional production of hydrogen peroxide, up to levels approx. double the basal levels. Nuclear translocation of the NF-kappaB p65 subunit, DNA-binding and gene transactivation were thus investigated in Me665/2/60 cells whose GGT activity was modulated by means of substrates or inhibitors. Stimulation of GGT activity resulted in increased nuclear translocation of p65, while on the other hand NF-kappaB DNA binding and gene transactivation were paradoxically decreased. NF-kappaB DNA binding could be restored by treating cell lysates with the thiol-reducing agent dithiothreitol (DTT). Treatment of cells with exogenous hydrogen peroxide did not affect NF-kappaB activation status.
CONCLUSIONS: Altogether, the data obtained indicate that GGT activity may impair the redox status of thiols that is critical for NF-kappaB DNA binding and gene transactivation, through the production of prooxidant species allegedly distinct from hydrogen peroxide. GGT activity therefore appears to be an additional factor in modulation of NF-kappaB transcriptional activity in melanoma, capable of hindering NF-kappaB DNA binding even in conditions where continuous oxidative stress would favor NF-kappaB nuclear translocation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14606649     DOI: 10.1177/030089160308900416

Source DB:  PubMed          Journal:  Tumori        ISSN: 0300-8916


  3 in total

1.  Hepatocyte CREBH deficiency aggravates inflammatory liver injury following chemokine-dependent neutrophil infiltration through upregulation of NF-κB p65 in mice.

Authors:  Jung-Ran Noh; Jae-Hoon Kim; Soon-Young Na; In Bok Lee; Yun Jeong Seo; Jung Hyeon Choi; Youngwon Seo; Tae Geol Lee; Hueng-Sik Choi; Yong-Hoon Kim; Chul-Ho Lee
Journal:  Arch Toxicol       Date:  2019-12-03       Impact factor: 5.153

2.  Chemiluminescent nanomicelles for imaging hydrogen peroxide and self-therapy in photodynamic therapy.

Authors:  Rui Chen; Luzhong Zhang; Jian Gao; Wei Wu; Yong Hu; Xiqun Jiang
Journal:  J Biomed Biotechnol       Date:  2011-06-15

3.  Non enzymatic upregulation of tissue factor expression by gamma-glutamyl transferase in human peripheral blood mononuclear cells.

Authors:  Valentina Scalise; Cristina Balia; Silvana Cianchetti; Tommaso Neri; Vittoria Carnicelli; Riccardo Zucchi; Maria Franzini; Alessandro Corti; Aldo Paolicchi; Alessandro Celi; Roberto Pedrinelli
Journal:  Thromb J       Date:  2016-11-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.